| scholarly article | Q13442814 |
| P50 | author | Nikos Protonotarios | Q18281573 |
| Gaetano Thiene | Q29840356 | ||
| Barbara Bauce | Q29840367 | ||
| Adalena Tsatsopoulou | Q29840392 | ||
| Thomas Wichter | Q82083870 | ||
| Jeffrey A Towbin | Q87444535 | ||
| James P Daubert | Q87446628 | ||
| Jonathan S Steinberg | Q88011806 | ||
| Harikrishna Tandri | Q90794759 | ||
| Danita M Yoerger Sanborn | Q108327978 | ||
| Richard Hauer | Q108328001 | ||
| Duane L Sherrill | Q114418205 | ||
| Moniek G P J Cox | Q117194800 | ||
| Jeffrey E Saffitz | Q117194801 | ||
| William McKenna | Q37375368 | ||
| Michael H. Picard | Q37386535 | ||
| David A. Bluemke | Q39818611 | ||
| Domenico Corrado | Q56529119 | ||
| Wojciech Zareba | Q63963026 | ||
| Hugh Calkins | Q67190496 | ||
| Guy Fontaine | Q77739534 | ||
| P2093 | author name string | Andrea Nava | |
| Frank I Marcus | |||
| Cristina Basso | |||
| Kathleen Gear | |||
| P2860 | cites work | Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy | Q24306039 |
| Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene | Q24656100 | ||
| Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma | Q28143046 | ||
| Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis | Q28256371 | ||
| Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2 | Q28267888 | ||
| Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q28274829 | ||
| Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy | Q28280387 | ||
| Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy | Q28282549 | ||
| Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy | Q28288328 | ||
| Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression | Q28293747 | ||
| Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study | Q30489889 | ||
| Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin | Q33147005 | ||
| Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. | Q33175413 | ||
| Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). | Q33910305 | ||
| Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? | Q34395507 | ||
| Arrhythmogenic right ventricular cardiomyopathy: a 'final common pathway' that defines clinical phenotype | Q79782202 | ||
| Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria | Q80593673 | ||
| Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteria | Q80974783 | ||
| Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia | Q81520934 | ||
| Do patients with right ventricular outflow tract ventricular arrhythmias have a normal right ventricular wall motion? A quantitative analysis compared to normal subjects | Q81823758 | ||
| Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria | Q82088303 | ||
| Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity | Q83026674 | ||
| New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q84754813 | ||
| Prevalence of T-wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia | Q94437210 | ||
| DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q34568365 | ||
| Right ventricular cardiomyopathy and sudden death in young people | Q34687427 | ||
| Right ventricular dysplasia: a report of 24 adult cases | Q34714742 | ||
| Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International S | Q34727600 | ||
| MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. | Q35161701 | ||
| No detection of enteroviral genome in the myocardium of patients with arrhythmogenic right ventricular cardiomyopathy | Q35396351 | ||
| Complementary role of echocardiography and cardiac magnetic resonance in the non-invasive evaluation of suspected arrhythmogenic right ventricular cardiomyopathy | Q35845329 | ||
| Genetics of right ventricular cardiomyopathy | Q36230660 | ||
| Evaluation of the normal values for signal-averaged electrocardiogram | Q36752173 | ||
| Guidelines for autopsy investigation of sudden cardiac death | Q36977658 | ||
| Quantitative assessment of angiographic right ventricular wall motion in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). | Q40169874 | ||
| Arrhythmogenic right ventricular dysplasia, a cell adhesion cardiomyopathy: insights into disease pathogenesis from preliminary genotype--phenotype assessment | Q42829722 | ||
| Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy | Q46630214 | ||
| Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisited. | Q47604997 | ||
| Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q51442238 | ||
| Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis. | Q51945069 | ||
| [Significance of lymphoplasmocytic infiltration in arrhythmogenic right ventricular dysplasia. Apropos of 3 own cases and review of the literature] | Q52207617 | ||
| Evaluation of new software for angiographic determination of right ventricular volumes. | Q52935698 | ||
| Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q53291585 | ||
| Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1 | Q55670706 | ||
| Feasibility and Variability of Three Dimensional Echocardiography in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Q57736357 | ||
| Normal Reference Values for the Adult Right Ventricle by Magnetic Resonance Imaging | Q57736398 | ||
| Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging | Q57736500 | ||
| MRI of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia | Q57736548 | ||
| Cardiovascular Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy Revisited | Q57901962 | ||
| Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease) | Q59218717 | ||
| Diagnostic Value of Endomyocardial Biopsy Guided by Electroanatomic Voltage Mapping in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia | Q59248800 | ||
| Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria | Q59286856 | ||
| Arrhythmogenic right ventricular cardiomyopathy | Q64043862 | ||
| Cardiac arrhythmias and atrioventricular block in a cohort of asymptomatic individuals without heart disease | Q79157383 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diagnosis | Q16644043 |
| arrhythmogenic right ventricular cardiomyopathy | Q2555727 | ||
| P304 | page(s) | 1533-1541 | |
| P577 | publication date | 2010-02-19 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. | |
| P478 | volume | 121 |
| Q38907482 | 12-Lead electrocardiogram as a predictor of sudden cardiac death: from epidemiology to clinical practice. |
| Q46502909 | 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. |
| Q83875569 | A 61-year-old patient with activity-related wide complex tachycardia |
| Q55275370 | A Prenatal Case of Arrhythmogenic Right Ventricular Dysplasia. |
| Q33167271 | A case of arrhythmogenic right ventricular cardiomyopathy in a 70-year-old patient |
| Q42767946 | A case of arrythmogenic right ventricular cardiomyopathy in a middle-aged woman |
| Q64226509 | A case of desmoplakin mutation and delayed arrhythmogenic right ventricular cardiomyopathy/dysplasia after atrial septal defect closure |
| Q33806088 | A classic case of arrhythmogenic right ventricular cardiomyopathy (ARVC) and literature review. |
| Q46113022 | A death following hemopericardium due to rupture of a right ventricular aneurysm due to a congenital ventricular septal defect |
| Q35603716 | A fishing trip to cure arrhythmogenic cardiomyopathy? |
| Q58567899 | A large familial pathogenic Plakophilin-2 gene () deletion manifesting with sudden cardiac death and lone atrial fibrillation: Evidence for alternating atrial and ventricular phenotypes |
| Q38816327 | A meta-analysis for echocardiographic assessment of right ventricular structure and function in ARVC |
| Q89896244 | A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy Cohort |
| Q24336412 | A novel desmocollin-2 mutation reveals insights into the molecular link between desmosomes and gap junctions |
| Q38644404 | A novel noninvasive surface ECG analysis using interlead QRS dispersion in arrhythmogenic right ventricular cardiomyopathy |
| Q36200056 | A unique association of arrhythmogenic right ventricular dysplasia and acute myocarditis, as assessed by cardiac MRI: a case report |
| Q36699635 | Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt/β-catenin signaling |
| Q38815949 | Advances in the Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy |
| Q35467456 | Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. |
| Q33164904 | An ECG changed the life of a young boy: a case of arrhythmogenic right ventricular dysplasia |
| Q46346611 | An adolescent with possible arrhythmogenic right ventricular dysplasia and long QT syndrome: evaluation and management. |
| Q30394854 | Analysis of ventricular function by CT |
| Q39422223 | Animal models of arrhythmogenic right ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeutics |
| Q57901722 | Are We Nearly There Yet Progress in the Prevention of Sudden Cardiac Death in the Young |
| Q37782455 | Arrhythmia and Right Heart Disease: From Genetic Basis to Clinical Practice |
| Q38288215 | Arrhythmogenic Cardiomyopathy - New Insights into Disease Mechanisms and Drug Discovery |
| Q41205053 | Arrhythmogenic Noncompaction Cardiomyopathy: Is There an Echocardiographic Phenotypic Overlap of Two Distinct Cardiomyopathies? |
| Q33166353 | Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias. |
| Q37635046 | Arrhythmogenic Right Ventricle in Left Ventricular Non-compaction - In Response to the Letter to the Editor "Diagnostic Dilemmas for Underlying Pathophysiology of Arrhythmias Originating from the Right Ventricle" |
| Q36887235 | Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature Review |
| Q41572662 | Arrhythmogenic Right Ventricular Cardiomyopathy in an Endurance Athlete Presenting with Ventricular Tachycardia and Normal Right Ventricular Function |
| Q90734431 | Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An Updated Review of Diagnosis and Management |
| Q89958699 | Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy |
| Q38826183 | Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy. |
| Q28069859 | Arrhythmogenic Right Ventricular Dysplasia in Neuromuscular Disorders |
| Q33906065 | Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management |
| Q86808670 | Arrhythmogenic right ventricular cardiomyopathy |
| Q34465268 | Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update |
| Q27317681 | Arrhythmogenic right ventricular cardiomyopathy (ARVC): case report and review of literature |
| Q33161666 | Arrhythmogenic right ventricular cardiomyopathy 2012: diagnostic challenges and treatment |
| Q90289425 | Arrhythmogenic right ventricular cardiomyopathy and left atrial tachycardia: a case report |
| Q40535786 | Arrhythmogenic right ventricular cardiomyopathy in a patient with schizophrenia |
| Q33166363 | Arrhythmogenic right ventricular cardiomyopathy in a weimaraner |
| Q30537711 | Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance |
| Q41773398 | Arrhythmogenic right ventricular cardiomyopathy with biventricular involvement and heart failure in a 9-year old girl |
| Q33166380 | Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis |
| Q84905617 | Arrhythmogenic right ventricular cardiomyopathy. What is needed for a cure? |
| Q33159766 | Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update |
| Q34780116 | Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges |
| Q95729750 | Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis |
| Q54114284 | Arrhythmogenic right ventricular cardiomyopathy: implications of next-generation sequencing in appropriate diagnosis. |
| Q82388240 | Arrhythmogenic right ventricular dysplasia |
| Q89920273 | Arrhythmogenic right ventricular dysplasia/cardiomyopathy |
| Q42431991 | Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): we׳ve come a long way, baby |
| Q49617546 | Arrhythmogenic right ventricular dysplasia/cardiomyopathy: an electrocardiogram-based review |
| Q60922442 | Arrythmogenic Right Ventricular Cardiomiopathy/Dysplasia (ARVC/D) - What We Have Learned after 40 Years of the Diagnosis of This Clinical Entity |
| Q90602761 | Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An 123I-metaiodobenzylguanidine SPECT/CT study |
| Q38191894 | Assessment of the myocardium with cardiac computed tomography. |
| Q30455514 | Assessment of the right ventricle with cardiovascular magnetic resonance at 7 Tesla |
| Q35847506 | Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiom |
| Q87948361 | Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricu |
| Q33165469 | Association of tricuspid annular plane systolic excursion with survival time in Boxer dogs with ventricular arrhythmias |
| Q85190808 | At the heart of genetic testing |
| Q57152063 | Athlete's Heart: Diagnostic Challenges and Future Perspectives |
| Q62667913 | Atypical case of post-partum cardiomyopathy: an overlap syndrome with arrhythmogenic right ventricular cardiomyopathy? |
| Q37703918 | Atypical clinical presentation of arrhythmogenic biventricular cardiomyopathy. |
| Q52867745 | Autosomal Recessive Nonsyndromic Arrhythmogenic Right Ventricular Cardiomyopathy without Cutaneous Involvements: A Novel Mutation. |
| Q50450720 | Beat-to-beat T-wave amplitude variability in the risk stratification of right ventricular outflow tract-premature ventricular complex patients |
| Q33565907 | Beyond the Electrocardiogram: Mutations in Cardiac Ion Channel Genes Underlie Nonarrhythmic Phenotypes |
| Q34306386 | Biventricular myocardial strain analysis in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) using cardiovascular magnetic resonance feature tracking |
| Q51735337 | Blockade of the renin-angiotensin-aldosterone system in patients with arrhythmogenic right ventricular dysplasia: A double-blind, multicenter, prospective, randomized, genotype-driven study (BRAVE study). |
| Q38470875 | CMR in Heart Failure. |
| Q57665132 | CSI position statement on management of heart failure in India |
| Q51479179 | Calculation of right ventricular stroke volume in short-axis MR images using the equation of the tricuspid plane. |
| Q57175468 | Cardiac Adaption to Exercise Training: the Female Athlete |
| Q36235564 | Cardiac MR enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries |
| Q97520854 | Cardiac Magnetic Resonance in Nonischemic Cardiomyopathies |
| Q35075557 | Cardiac and non-cardiac causes of T-wave inversion in the precordial leads in adult subjects: A Dutch case series and review of the literature |
| Q30432349 | Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 1: current applications |
| Q56764963 | Cardiac magnetic resonance imaging in clinical practice |
| Q39255836 | Cardiac magnetic resonance imaging in heart failure: where the alphabet begins! |
| Q53552620 | Cardiac magnetic resonance imaging reveals extensive biventricular fibrosis and inflammation challenging the diagnosis of ARVC. |
| Q46509514 | Cardiac sarcoid or arrhythmogenic right ventricular cardiomyopathy: a role for positron emission tomography (PET)? |
| Q41692330 | Cardiac sarcoidosis mimicking arrhythmogenic right ventricular dysplasia in a patient presenting with monomorphic ventricular tachycardia |
| Q36591651 | Cardiac sarcoidosis with severe involvement of the right ventricle: a case report |
| Q28303564 | Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling |
| Q35673091 | Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. |
| Q46044324 | Cardiological diseases |
| Q38561469 | Cardiomyopathies and the Armed Forces. |
| Q38020821 | Cardiomyopathies: focus on cardiovascular magnetic resonance. |
| Q95260947 | Cardiovascular magnetic resonance imaging for structural heart disease |
| Q37848215 | Cardiovascular magnetic resonance in heart failure |
| Q30430740 | Cardiovascular magnetic resonance: applications in daily practice |
| Q40101715 | Cardiovascular pre-participation screening in young athletes: Recommendations of the Association of European Paediatric Cardiology |
| Q53712556 | Case 1/2018 - Young Male with Heart Disease Expressed Mainly as Ventricular Arrhythmia, Right Ventricular Dysfunction and Syncope. |
| Q41451219 | Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2. |
| Q57143043 | Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy |
| Q64088946 | Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach |
| Q34919617 | Cell junctions in the specialized conduction system of the heart |
| Q44712988 | Changes in follow-up ECG and signal-averaged ECG in patients with arrhythmogenic right ventricular cardiomyopathy |
| Q33165363 | Characteristics of idiopathic ventricular tachycardia originating above the pulmonary valve |
| Q64081772 | Characterization of a Unique Form of Arrhythmic Cardiomyopathy Caused by Recessive Mutation in LEMD2 |
| Q38900012 | Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells. |
| Q47737719 | Circulating microRNAs in arrhythmogenic right ventricular cardiomyopathy with ventricular arrhythmia. |
| Q47700325 | Circulatory Flow Restoration Versus Cardiopulmonary Resuscitation: New Therapeutic Approach in Sudden Cardiac Arrest |
| Q33166782 | Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry |
| Q57901708 | Clinical Significance of Epsilon Waves in Arrhythmogenic Cardiomyopathy |
| Q27310698 | Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy |
| Q42676363 | Clinical and genetic characterization of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy caused by a plakophilin-2 splice mutation |
| Q39435410 | Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age. |
| Q92376906 | Clinical features and arrhythmic complications of patients with pediatric-onset arrhythmogenic right ventricular dysplasia |
| Q43934270 | Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging |
| Q38268280 | Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy |
| Q35488614 | Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations. |
| Q53707872 | Clinical presentation and echocardiographic characteristics of Uhl's anomaly. |
| Q89367247 | Clinical profile in arrhythmogenic cardiomyopathy and a recessive plakophilin-2 gene mutation |
| Q33163468 | Clinico-radiological profile of arrhythmogenic right ventricular dysplasia at a tertiary care center: Two year experience |
| Q50533804 | Co-inheritance of mutations associated with arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy. |
| Q41461021 | Coexistence of congenital left ventricular aneurysm and prominent left ventricular trabeculation in a patient with LDB3 mutation: a case report |
| Q33794419 | Comparison of conventional autopsy and magnetic resonance imaging in determining the cause of sudden death in the young |
| Q99613010 | Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy |
| Q37567288 | Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia |
| Q53554275 | Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy. |
| Q37147335 | Complication rate of transfemoral endomyocardial biopsy with fluoroscopic and two-dimensional echocardiographic guidance: a 10-year experience of 228 consecutive procedures |
| Q33781552 | Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy |
| Q33643955 | Congenital heart disease confounding the diagnosis of arrhythmogenic right ventricular cardiomyopathy |
| Q37572134 | Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model |
| Q38246324 | Current clinical applications of cardiovascular magnetic resonance imaging |
| Q38206258 | Desmosomes in the heart: a review of clinical and mechanistic analyses |
| Q24296437 | Detection of genomic deletions of PKP2 in arrhythmogenic right ventricular cardiomyopathy |
| Q88651362 | Diagnosing ARVC in Pediatric Patients Applying the Revised Task Force Criteria: Importance of Imaging, 12-Lead ECG, and Genetics |
| Q36251940 | Diagnosis of arrhythmogenic right ventricular cardiomyopathy |
| Q58732032 | Diagnostic Yield of Genetic Testing in Young Athletes With T-Wave Inversion |
| Q38912706 | Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonance |
| Q88454366 | Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient |
| Q35982138 | Diagnostic dilemmas: overlapping features of brugada syndrome and arrhythmogenic right ventricular cardiomyopathy |
| Q38113123 | Diagnostic use of the endomyocardial biopsy: a consensus statement |
| Q50499373 | Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. |
| Q89502845 | Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy |
| Q46774887 | Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study. |
| Q34522622 | Dilated Cardiomyopathy With Conduction Disease and Arrhythmia |
| Q64934138 | Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. |
| Q26864740 | Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis |
| Q33889845 | Dynamic conduction and repolarisation changes in early arrhythmogenic right ventricular cardiomyopathy versus benign outflow tract ectopy demonstrated by high density mapping & paced surface ECG analysis |
| Q92808520 | Early Left Ventricular Involvement Detected by Cardiovascular Magnetic Resonance Feature Tracking in Arrhythmogenic Right Ventricular Cardiomyopathy: The Effects of Left Ventricular Late Gadolinium Enhancement and Right Ventricular Dysfunction |
| Q89913819 | Echocardiographic assessment of the right heart in adults: a practical guideline from the British Society of Echocardiography |
| Q48192105 | Echocardiographic assessment of the right ventricle in the current era: Application in clinical practice. |
| Q51280823 | Effect of hydration status on atrial and ventricular volumes and function in healthy adult volunteers. |
| Q30373557 | Effects of slice orientation on reproducibility of sequential assessment of right ventricular volumes and ejection fraction: short-axis vs transverse SSFP cine cardiovascular magnetic resonance. |
| Q38928152 | Electrical Storm in ICD Recipients with Arrhythmogenic Right Ventricular Cardiomyopathy |
| Q38401116 | Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging. |
| Q42318510 | Electrical storm might be the initial presentation of arrhythmogenic right ventricular cardiomyopathy |
| Q53212654 | Electroanatomic Correlates of Depolarization Abnormalities in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. |
| Q38025348 | Electrocardiogram interpretation in the athlete |
| Q35028503 | Electrocardiographic (ECG) clues to differentiate idiopathic right ventricular outflow tract tachycardia (RVOTT) from arrhythmogenic right ventricular cardiomyopathy (ARVC). |
| Q38590641 | Electrocardiographic T Wave Abnormalities and the Risk of Sudden Cardiac Death: The Finnish Perspective. |
| Q46704820 | Electrocardiographic anterior T-wave inversion in athletes of different ethnicities: differential diagnosis between athlete's heart and cardiomyopathy. |
| Q42290843 | Electrocardiographic differentiation of idiopathic right ventricular outflow tract ectopy from early arrhythmogenic right ventricular cardiomyopathy. |
| Q41160620 | Electrocardiographic patterns of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy |
| Q36131473 | Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study. |
| Q92715746 | Endomyocardial biopsy in patients with acute myocarditis, idiopathic dilated cardiomyopathy, and arrhythmogenic right ventricular dysplasia |
| Q38420171 | Epicardial myocardial strain abnormalities may identify the earliest stages of arrhythmogenic cardiomyopathy. |
| Q64119517 | Epsilon wave: A review of historical aspects |
| Q89441783 | Epsilon waves: Milestones in the discovery and progress |
| Q26796261 | European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society |
| Q38571627 | European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. |
| Q34716129 | Evaluation and classification of right ventricular wall motion abnormalities in healthy subjects by 3-tesla cardiovascular magnetic resonance imaging |
| Q42279857 | Evaluation of Coronary Arteries in Non-Ischemic Cardiomyopathies: A Case Report |
| Q38608486 | Evolving Approaches to Genetic Evaluation of Specific Cardiomyopathies |
| Q38006744 | Evolving diagnostic and prognostic imaging of the various cardiomyopathies |
| Q42690768 | Exercise and Competitive Sport: Physiology, Adaptations, and Uncertain Long-Term Risks |
| Q38069203 | Exercise and heart disease: from athletes and arrhythmias to hypertrophic cardiomyopathy and congenital heart disease |
| Q49679366 | Exercise and the right ventricle: a potential Achilles' heel |
| Q35115127 | Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations. |
| Q39506391 | Familial dilated cardiomyopathy. Clinical and genetic characteristics. |
| Q50484426 | Family-based cardiac screening in relatives of victims of sudden arrhythmic death syndrome. |
| Q33896028 | Fat in left ventricular myocardium assessed by steady-state free precession pulse sequences. |
| Q55397299 | Fatty Images of the Heart: Spectrum of Normal and Pathological Findings by Computed Tomography and Cardiac Magnetic Resonance Imaging. |
| Q36235761 | Fatty lesions in and around the heart: a pictorial review |
| Q41595269 | Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia/ cardiomyopathy: a multisoftware feasibility and clinical implementation study |
| Q51550065 | Fetal arrhythmogenic right ventricular cardiomyopathy with double mutations in TMEM43. |
| Q61445718 | Fifty Years of Ventricular Tachycardia in a Single Patient |
| Q93169958 | Finding the right pathway is the key to success |
| Q42339351 | First Reported Case of Arrhythmogenic Right Ventricular Cardiomyopathy in Oman |
| Q33160839 | Follow-up with exercise test of effort-induced ventricular arrhythmias linked to ryanodine receptor type 2 gene mutations |
| Q48456068 | Fontan-like circulation as a criterion for heart transplantation in arrhythmogenic right ventricular dysplasia |
| Q43612514 | Frequency of Electrocardiographic Changes in Trained Athletes in the Republic of Macedonia |
| Q88867619 | Frequency of genetic variants associated with arrhythmogenic right ventricular cardiomyopathy in the genome aggregation database |
| Q34212672 | Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathy |
| Q38680570 | Galectin-3 correlates with arrhythmogenic right ventricular cardiomyopathy and predicts the risk of ventricular -arrhythmias in patients with implantable defibrillators |
| Q90082106 | Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy |
| Q39270856 | Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy |
| Q37786123 | Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases |
| Q38118161 | Genetic etiology and evaluation of sudden cardiac death |
| Q64944906 | Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy. |
| Q38028676 | Genetics of sudden cardiac death in children and young athletes. |
| Q52606411 | Genome-wide association study and meta-analysis identify loci associated with ventricular and supraventricular ectopy. |
| Q39004331 | Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease. |
| Q47096866 | Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology |
| Q33815633 | HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011 |
| Q90092939 | Handling of Ventricular Fibrillation in the Emergency Setting |
| Q30446792 | Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI. |
| Q38231508 | Heart muscle disease and cardiovascular magnetic resonance imaging |
| Q35147756 | High resolution systematic digital histological quantification of cardiac fibrosis and adipose tissue in phospholamban p.Arg14del mutation associated cardiomyopathy |
| Q38211720 | How to recognize epicardial origin of ventricular tachycardias? |
| Q33168004 | ICD Therapy In RVOT-VT And Early Stage ARVD/C Patients |
| Q53611981 | Identification of arrhythmogenic right ventricular cardiomyopathy-causing gene mutations in young sudden unexpected death autopsy cases. |
| Q37695559 | Identifying model inaccuracies and solution uncertainties in noninvasive activation-based imaging of cardiac excitation using convex relaxation |
| Q30570679 | Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia |
| Q35888986 | Image quality assessment of the right ventricle with three different delayed enhancement sequences in patients suspected of ARVC/D. |
| Q35078951 | Imaging of programmed cell death in arrhythmogenic right ventricle cardiomyopathy/dysplasia |
| Q38253105 | Imaging of the right heart--CT and CMR. |
| Q30473247 | Imaging phenotype vs genotype in nonhypertrophic heritable cardiomyopathies: dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy |
| Q37778986 | Imaging the right ventricle--current state of the art. |
| Q44825529 | Impact of cardiac magnetic resonance imaging on cardiac device and surgical therapy: a prospective study |
| Q38191111 | Impact of ethnicity on cardiac adaptation to exercise |
| Q42182575 | Impact of new electrocardiographic criteria in arrhythmogenic cardiomyopathy |
| Q39037051 | Importance Of Delayed Enhanced Cardiac MRI In Idiopathic RVOT-VT: Differentiating Mimics Including Early Stage ARVC And Cardiac Sarcoidosis |
| Q46096227 | Importance of Ventricular Tachycardia Induction and Mapping for Patients Referred for Epicardial Ablation |
| Q34447898 | In vitro functional analyses of arrhythmogenic right ventricular cardiomyopathy-associated desmoglein-2-missense variations |
| Q37676235 | Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. |
| Q42288713 | Incremental value of electroanatomical mapping for the diagnosis of arrhythmogenic right ventricular cardiomyopathy in a patient with sustained ventricular tachycardia. |
| Q56082644 | Inherited Cardiomyopathies |
| Q48501295 | Inherited cardiomyopathies and sports participation |
| Q38886312 | International recommendations for electrocardiographic interpretation in athletes |
| Q49417067 | Intracardiac ultrasound to detect aneurysm in arrhythmogenic right ventricular dysplasia/cardiomyopathy |
| Q64087983 | Intraoperative sudden cardiac death in pediatric patients - Calamity yet to overcome? |
| Q35999436 | Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes |
| Q33948529 | Is cardiac MRI an effective test for arrhythmogenic right ventricular cardiomyopathy diagnosis? |
| Q64232597 | Isolated diastolic potentials as predictors of success in ablation of right ventricular outflow tract idiopathic premature ventricular contractions |
| Q55186335 | Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients. |
| Q91827343 | LEFT VENTRICULAR LEAD PLACEMENT FOR PACING AND SENSING IN A PATIENT WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY UNDERGOING ICD IMPLANTATION |
| Q51646628 | LMNA-Mediated Arrhythmogenic Right Ventricular Cardiomyopathy and Charcot-Marie-Tooth Type 2B1: A Patient-Discovered Unifying Diagnosis. |
| Q64260161 | Late presentation of arrhythmogenic right ventricular cardiomyopathy in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene: a case report |
| Q90441553 | Left Ventricular Involvement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Predicts Adverse Clinical Outcomes: A Cardiovascular Magnetic Resonance Feature Tracking Study |
| Q40001914 | Left bundle branch block morphology ventricular tachycardia in a marathon runner |
| Q35171347 | Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy - a cardiac magnetic resonance imaging study |
| Q33850323 | Left ventricular myocardial strain in ventricular arrhythmia without structural heart disease using cardiac magnetic resonance |
| Q64906938 | Life-long tailoring of diagnosis and management of patients with idiopathic ventricular fibrillation-future perspectives in research. |
| Q33168780 | Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment |
| Q48726319 | Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy |
| Q40357862 | Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death |
| Q35997409 | Long-term outcomes of catheter ablation of ventricular tachycardia in patients with structural heart disease |
| Q30358689 | Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study. |
| Q47575418 | Lower than expected burden of premature ventricular contractions impairs myocardial function |
| Q34903406 | MR and CT imaging of Arrhythmogenic Cardiomyopathy |
| Q33355124 | MRI for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) |
| Q42431617 | Magnetic Resonance Imaging Assessment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia in Children |
| Q38100155 | Magnetic resonance imaging in the evaluation of congestive cardiac failure |
| Q35166584 | Management of a rare case of arrhythmogenic right ventricular dysplasia in pregnancy: a case report |
| Q26782057 | Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries |
| Q38568707 | Mechanism, diagnosis, and treatment of outflow tract tachycardia |
| Q36723709 | Mechanisms of arrhythmias and conduction disorders in older adults |
| Q24306468 | Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutations |
| Q33881246 | MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy. |
| Q42805646 | MicroRNA-130a Regulation of Desmocollin 2 in a Novel Model of Arrhythmogenic Cardiomyopathy |
| Q82662379 | Microvascular dysfunction in nonfailing arrhythmogenic right ventricular cardiomyopathy |
| Q34250400 | Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations |
| Q30378666 | Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside. |
| Q47827654 | Multichannel electrocardiogram diagnostics for the diagnosis of arrhythmogenic right ventricular dysplasia. |
| Q53066001 | Multiplane two-dimensional strain echocardiography for segmental analysis of right ventricular mechanics: new-RV study. |
| Q36731937 | Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies |
| Q37676232 | Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced |
| Q64012839 | Mutations in ILK, encoding integrin-linked kinase, are associated with arrhythmogenic cardiomyopathy |
| Q54332402 | Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. |
| Q82429955 | Myocardial Fat at Cardiac Imaging: How Can We Differentiate Pathologic from Physiologic Fatty Infiltration? |
| Q34090483 | Myocardial edema imaging by cardiovascular magnetic resonance: current status and future potential. |
| Q38377428 | Myocardial fat as a part of cardiac visceral adipose tissue: physiological and pathophysiological view |
| Q57654519 | Myocardial fat overgrowth in Proteus syndrome |
| Q90632760 | Natural History of Arrhythmogenic Cardiomyopathy |
| Q55101134 | Naxos disease: from the origin to today. |
| Q28083928 | New Imaging Technologies To Characterize Arrhythmic Substrate |
| Q38850894 | New approaches to predicting the risk of sudden death. |
| Q38211723 | New electrocardiographic features in Brugada syndrome |
| Q33165264 | New strategies for ventricular tachycardia and ventricular fibrillation ablation |
| Q89661633 | Next-generation sequencing identified novel Desmoplakin frame-shift variant in patients with Arrhythmogenic cardiomyopathy |
| Q38588152 | Nomenclature and systems of classification for cardiomyopathy in children |
| Q90215796 | Non-sarcomeric causes of heart failure |
| Q36585526 | Noninvasive Multimodality Imaging in ARVD/C |
| Q34646112 | Noninvasive cardiac screening in young athletes with ventricular arrhythmias. |
| Q37983728 | Noninvasive imaging modalities and sudden cardiac arrest in the young: can they help distinguish subjects with a potentially life-threatening abnormality from normals? |
| Q89913812 | Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British Society of Echocardiography |
| Q52330345 | Novel Insights and Treatment Strategies for Right Heart Failure. |
| Q40334492 | Novel electrocardiographic criteria for the diagnosis of arrhythmogenic right ventricular cardiomyopathy |
| Q35877751 | Novel frame-shift mutation in PKP2 associated with arrhythmogenic right ventricular cardiomyopathy: a case report |
| Q52585976 | Number of pregnancies and subsequent phenotype in a cross-sectional cohort of women with arrhythmogenic cardiomyopathy. |
| Q38846518 | Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease |
| Q37980342 | Overview of sudden cardiac death in young athletes. |
| Q38310158 | Passive ventricular remodeling in cardiac disease: focus on heterogeneity. |
| Q28085550 | Pathogenesis of Arrhythmogenic Cardiomyopathy |
| Q38859214 | Pectus excavatum: echocardiographic, pathophysiologic, and surgical insights |
| Q64965420 | Personalized Interpretation and Clinical Translation of Genetic Variants Associated With Cardiomyopathies. |
| Q46269501 | Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement |
| Q28253770 | Phenotypic analysis of arrhythmogenic cardiomyopathy in the Hutterite population: role of electrocardiogram in identifying high-risk desmocollin-2 carriers |
| Q33165969 | Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy. |
| Q38813888 | Physical Activity, Endurance Exercise, and Excess-Can One Overdose? |
| Q33815199 | Pitfalls in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia |
| Q41107820 | Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm. |
| Q35949057 | Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy |
| Q38074319 | Postmortem imaging of sudden cardiac death |
| Q51834996 | Predictors and Therapy of Cardiomyopathy Caused by Frequent Ventricular Ectopy. |
| Q33161842 | Predictors of appropriate ICD therapy in patients with arrhythmogenic right ventricular cardiomyopathy: long term experience of a tertiary care center |
| Q36577311 | Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy. |
| Q37238663 | Prevalence and prognostic significance of exercise-induced nonsustained ventricular tachycardia in asymptomatic volunteers: BLSA (Baltimore Longitudinal Study of Aging). |
| Q58580209 | Profile of patients presenting with sustained ventricular tachycardia in a tertiary care center |
| Q37010626 | Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy |
| Q35068177 | Prognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease |
| Q52355584 | Pulmonary arterial hypertension: pathogenesis and clinical management. |
| Q64104540 | QRS alternans due to localized intraventricular block during ventricular tachycardia in Uhl's anomaly: a case report |
| Q89805299 | Quantitative Approach to Fragmented QRS in Arrhythmogenic Cardiomyopathy: From Disease towards Asymptomatic Carriers of Pathogenic Variants |
| Q47913364 | Quantitative analysis of PKP2 and neighbouring genes in a patient with arrhythmogenic right ventricular cardiomyopathy caused by heterozygous PKP2 deletion. |
| Q36816108 | Quantitative analysis of myocardial tissue with digital autofluorescence microscopy. |
| Q38639575 | Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC). |
| Q53077201 | Reader- and instrument-dependent variability in the electrocardiographic assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy. |
| Q34644575 | Reappraisal of cardiac magnetic resonance imaging in idiopathic outflow tract arrhythmias. |
| Q28304979 | Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia |
| Q91911427 | Reflections on the early invasive clinical cardiac electrophysiology era through fifty manuscripts: 1967-1992 |
| Q57822608 | Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy |
| Q55365268 | Relations between right ventricular morphology and clinical, electrical and genetic parameters in Brugada Syndrome. |
| Q36709335 | Relationship Between Arrhythmogenic Right Ventricular Cardiomyopathy and Brugada Syndrome: New Insights From Molecular Biology and Clinical Implications. |
| Q90668307 | Relationship Between Electrocardiographic Findings and Cardiac Magnetic Resonance Phenotypes in Arrhythmogenic Cardiomyopathy |
| Q30562548 | Relationship between MDCT-imaged myocardial fat and ventricular tachycardia substrate in arrhythmogenic right ventricular cardiomyopathy |
| Q33552944 | Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction |
| Q38181533 | Remodeling of cell-cell junctions in arrhythmogenic cardiomyopathy |
| Q36716425 | Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy |
| Q42733827 | Response to Letter Regarding Article, "Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement". |
| Q43546020 | Resting ECG findings in elite football players |
| Q90382961 | Reversible methamphetamine-induced cardiomyopathy mimicking arrhythmogenic right ventricular cardiomyopathy with ventricular tachycardia |
| Q37984850 | Review of novel clinical applications of advanced, real-time, 3-dimensional echocardiography |
| Q53704446 | Revisiting Athlete's Heart Versus Pathologic Hypertrophy: ARVC and the Right Ventricle. |
| Q47653121 | Right Ventricular Arrhythmogenic Dysplasia in Cardiac Arrest. An Echocardiographic Pattern Not to Forget |
| Q37468972 | Right Ventricular Outflow Tract Arrhythmias: Benign Or Early Stage Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia? |
| Q41901149 | Right Ventricular Outflow Tract Tachycardia with Structural Abnormalities of the Right Ventricle and Left Ventricular Diverticulum |
| Q88873897 | Right bundle branch block and conduction disturbances in Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy |
| Q38911015 | Right heart imaging in patients with heart failure: a tale of two ventricles. |
| Q38253119 | Right heart structural and functional remodeling in athletes |
| Q42377424 | Right precordial-directed electrocardiographical markers identify arrhythmogenic right ventricular cardiomyopathy in the absence of conventional depolarization or repolarization abnormalities. |
| Q38811546 | Right ventricular assessment at cardiac MRI: initial clinical experience utilizing an IS-SENSE reconstruction |
| Q38252394 | Right ventricular cardiomyopathies: a multidisciplinary approach to diagnosis. |
| Q35620014 | Right ventricular cardiomyopathy meeting the arrhythmogenic right ventricular dysplasia revised criteria? Don't forget sarcoidosis! |
| Q30456010 | Right ventricular cardiovascular magnetic resonance imaging: normal anatomy and spectrum of pathological findings. |
| Q35261875 | Right ventricular obstructive hypertrophic cardiomyopathy in primary myo-adenylate deaminase deficiency. |
| Q40818100 | Right ventricular remodelling induced by exercise training in competitive athletes. |
| Q47936384 | Right ventricular scar-related ventricular tachycardia in nonischemic cardiomyopathy: Electrophysiological characteristics, mapping, and ablation of underlying heart disease. |
| Q36813646 | Right ventricular strain by MR quantitatively identifies regional dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy |
| Q48049808 | Right ventricular systolic function and mechanical dispersion identify patients with arrhythmogenic right ventricular cardiomyopathy. |
| Q36369424 | Right ventricular volume analysis by angiography in right ventricular cardiomyopathy |
| Q41552188 | Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators. |
| Q52776792 | Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. |
| Q83014367 | Risk stratification for prevention of sudden cardiac death |
| Q33163382 | Risk stratification in arrhythmogenic right ventricular cardiomyopathy. |
| Q30279246 | Role of Cardiac MR Imaging in Cardiomyopathies |
| Q26800070 | Role of Imaging in the Evaluation of Patients at Risk for Sudden Cardiac Death: Genotype-Phenotype Intersection |
| Q26744429 | Role of cardiac MRI in nonischemic cardiomyopathies |
| Q37980258 | Role of cardiac magnetic resonance imaging in assessing ischemic and nonischemic cardiomyopathies |
| Q56761537 | Role of genetic heart disease in sentinel sudden cardiac arrest survivors across the age spectrum |
| Q38338232 | Role of non-invasive imaging in the work-up of cardiomyopathies |
| Q30433243 | Role of strain imaging in right heart disease: a comprehensive review |
| Q33163606 | SCN5A mutation in Chinese patients with arrhythmogenic right ventricular dysplasia |
| Q37387146 | ST segment elevations: always a marker of acute myocardial infarction? |
| Q53341820 | Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicen |
| Q51821757 | Screening athletes for cardiovascular disease in Africa: a challenging experience. |
| Q57083780 | Sequenom MassARRAY approach in the arrhythmogenic right ventricular cardiomyopathy post-mortem setting: clinical and forensic implications |
| Q90367424 | Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β |
| Q35110260 | Shared desmosome gene findings in early and late onset arrhythmogenic right ventricular dysplasia/cardiomyopathy |
| Q55359580 | Signal-averaged electrocardiography: Past, present, and future. |
| Q47896111 | Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy |
| Q87287849 | Sports in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and desmosomal mutations |
| Q40010538 | Statistical evaluation of reproducibility of automated ECG measurements: an example from arrhythmogenic right ventricular dysplasia/cardiomyopathy clinic |
| Q38769217 | Strenuous Exercise and Cardiovascular Disease Outcomes |
| Q57450981 | Sudden Arrhythmic Death Syndrome: Diagnostic Yield of Comprehensive Clinical Evaluation of Pediatric First-Degree Relatives |
| Q64230001 | Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy |
| Q36458885 | Sudden Unexplained Death - Treating the Family |
| Q38823957 | Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance. |
| Q48355408 | Sudden cardiac death in isolated right ventricular hypertrabeculation/noncompaction cardiomyopathy. |
| Q38191069 | Sudden cardiac death in patients with nonischemic cardiomyopathy |
| Q38085134 | Sudden cardiac death in young athletes: preparticipation screening for underlying cardiovascular abnormalities and approaches to prevention |
| Q40344851 | Sudden unexplained death in the young: epidemiology, aetiology and value of the clinically guided genetic screening. |
| Q38657463 | Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies |
| Q28256845 | The ARVD/C genetic variants database: 2014 update |
| Q35816007 | The Different Substrate Characteristics of Arrhythmogenic Triggers in Idiopathic Right Ventricular Outflow Tract Tachycardia and Arrhythmogenic Right Ventricular Dysplasia: New Insight from Noncontact Mapping |
| Q42735967 | The ECG in arrhythmogenic right ventricular cardiomyopathy: ε-waves and anterior T-wave inversion |
| Q58613919 | The Female Athlete's Heart: Facts and Fallacies |
| Q33158796 | The ICD as primary prevention. Rare indications |
| Q37809077 | The Pathobiology of Arrhythmogenic Cardiomyopathy |
| Q57166458 | The Role of Cardiovascular Magnetic Resonance in Sports Cardiology; Current Utility and Future Perspectives |
| Q42749505 | The Value of Cardiac Magnetic Resonance Imaging in Evaluation of Pediatric Patients for Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy |
| Q91703824 | The chameleon of cardiology: cardiac sarcoidosis before and after heart transplantation |
| Q38000066 | The changing spectrum of arrhythmogenic (right ventricular) cardiomyopathy |
| Q37846095 | The diagnosis and management of ventricular arrhythmias |
| Q51133570 | The diagnostic performance of imaging methods in ARVC using the 2010 Task Force criteria. |
| Q28074493 | The genetic background of arrhythmogenic right ventricular cardiomyopathy |
| Q53026278 | The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging. |
| Q33161556 | The presence of giant epsilon waves in a patient with arrhythmogenic right ventricular cardiomyopathy. |
| Q38068352 | The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies |
| Q37822294 | The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy |
| Q34439332 | The role of cardiac magnetic resonance imaging in the evaluation of arrhythmogenic right ventricular dysplasia |
| Q34679867 | The role of endomyocardial biopsy in ARVC: looking beyond histology in search of new diagnostic markers. |
| Q38542918 | The role of genetic testing in unexplained sudden death |
| Q37057557 | The spectrum of epidemiology underlying sudden cardiac death |
| Q38005780 | The year of 2010 in electrocardiology. |
| Q44483582 | Thermogenic supplement use does not alter characteristics of sudden death in the young |
| Q28246696 | Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy |
| Q38255380 | Transcatheter closure of atrial septal defect associated with arrhythmogenic right ventricular cardiomyopathy: a case report and literature review |
| Q26799143 | Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement |
| Q26799094 | Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement |
| Q35125245 | Ultrastructural changes in cardiac myocytes from Boxer dogs with arrhythmogenic right ventricular cardiomyopathy |
| Q48246243 | Unipolar peak-negative voltage as an endocardial electrographic characteristic to predict overlying abnormal epicardial substrates in patients with right epicardial ventricular tachycardia |
| Q47155677 | Unique genetic background and outcome of non-Caucasian Japanese probands with arrhythmogenic right ventricular dysplasia/cardiomyopathy. |
| Q38177854 | Unveiling nonischemic cardiomyopathies with cardiac magnetic resonance |
| Q33600733 | Usefulness of precordial T-wave inversion to distinguish arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia arising from the right ventricular outflow tract |
| Q92568756 | Utility of genetic testing in athletes |
| Q38683303 | Utility of late gadolinium enhancement in pediatric cardiac MRI. |
| Q34796656 | Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia |
| Q34308404 | Ventricular arrhythmias and sudden cardiac death |
| Q38819031 | Ventricular fibrillation: triggers, mechanisms and therapies |
| Q38256157 | Ventricular tachycardia mapping and ablation in arrhythmogenic right ventricular cardiomyopathy/dysplasia: Lessons Learned |
| Q34782131 | Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. |
| Q38181532 | When rare illuminates common: how cardiocutaneous syndromes transformed our perspective on arrhythmogenic cardiomyopathy |
| Q38888147 | Whole exome sequencing with genomic triangulation implicates CDH2-encoded N-cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy |
| Q41694294 | Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy |
| Q35234588 | Yield of serial evaluation in at-risk family members of patients with ARVD/C. |
| Q85508713 | [Cardiovascular diseases in childhood] |
| Q33165762 | [Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies]. |
| Q86485517 | [Ventricular tachycardia under stress : Characteristic symptom or prognostic relevance?] |
Search more.